Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program product
    1.
    发明授权
    Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program product 有权
    癌症诊断支持系统,癌症诊断支持信息提供方法和计算机程序产品

    公开(公告)号:US08921114B2

    公开(公告)日:2014-12-30

    申请号:US12197714

    申请日:2008-08-25

    IPC分类号: G06F19/24 G06F19/20 G06F19/00

    CPC分类号: G06F19/24 G06F19/20

    摘要: A diagnosis support system for cancer is disclosed that comprises: a measurement value acquiring section for acquiring a measurement value of a first cancer patient; a sample data memory for storing sample data of a plurality of cancer patients different from the first patient; a reference range determination section for determining a reference range based on the measurement value of the first cancer patient; a display unit; and a display controller for controlling the display unit to display a diagnosis support screen showing the clinical information included in the sample data having measurement value within the reference range. A method of providing cancer diagnosis support information and a computer program product are also disclosed.

    摘要翻译: 公开了一种用于癌症的诊断支持系统,包括:测量值获取部分,用于获取第一癌症患者的测量值; 用于存储与第一患者不同的多个癌症患者的样本数据的样本数据存储器; 参考范围确定部分,用于基于第一癌症患者的测量值来确定参考范围; 显示单元; 以及显示控制器,用于控制显示单元显示诊断支持屏幕,其显示包含在具有参考范围内的测量值的样本数据中的临床信息。 还公开了提供癌症诊断支持信息的方法和计算机程序产品。

    METHOD FOR JUDGING RISK OF CANCER RECURRENCE, COMPUTER PROGRAM, AND COMPUTER SYSTEM
    2.
    发明申请
    METHOD FOR JUDGING RISK OF CANCER RECURRENCE, COMPUTER PROGRAM, AND COMPUTER SYSTEM 有权
    判断癌症复发风险的方法,计算机程序和计算机系统

    公开(公告)号:US20110246413A1

    公开(公告)日:2011-10-06

    申请号:US13074745

    申请日:2011-03-29

    IPC分类号: G06N5/04 C12Q1/48

    摘要: A method for judging a risk of cancer recurrence comprising: acquiring an activity value and expression level of a first cyclin dependent kinase (CDK) of a cell contained in tissues extracted from cancer patients, an activity value and expression level of a second CDK, and a number of Ki67-expressing cells or an expression level of Ki67; and judging a risk of cancer recurrence based on the acquired activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and a percentage of Ki67-expressing cells or the expression level of Ki67. A computer program product and a computer system are also disclosed.

    摘要翻译: 一种判断癌症复发风险的方法,包括:获得癌症患者提取的组织中含有的细胞的第一细胞周期蛋白依赖性激酶(CDK)的活性值和表达水平,第二CDK的活性值和表达水平,以及 多个Ki67表达细胞或Ki67表达水平; 根据获得的第一CDK的活性值和表达水平,第二CDK的活性值和表达量以及Ki67表达细胞的百分比或Ki67的表达水平来判断癌症复发的风险。 还公开了一种计算机程序产品和计算机系统。

    Method for judging feature of malignant tumor
    5.
    发明申请
    Method for judging feature of malignant tumor 失效
    判断恶性肿瘤特征的方法

    公开(公告)号:US20070202555A1

    公开(公告)日:2007-08-30

    申请号:US11711053

    申请日:2007-02-27

    IPC分类号: G01N33/574 G06F19/00

    摘要: A method for judging feature of malignant tumor is described. The method comprises obtaining step, first comparing step, second comparing step and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first cyclin dependent kinase (first CDK) contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second cyclin dependent kinase (second CDK) contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a cyclin contained in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature of the malignant tumor based on the comparison results of the first comparing step and the second comparing step.

    摘要翻译: 描述了判断恶性肿瘤特征的方法。 该方法包括获得步骤,第一比较步骤,第二比较步骤和判断步骤。 获得步骤包括基于包含在恶性肿瘤的肿瘤细胞中的第一细胞周期蛋白依赖性激酶(第一CDK)的活性和表达水平获得第一参数,第二参数基于第二细胞周期蛋白依赖性激酶的活性和表达水平( 第二CDK),基于第一参数和第二参数的第三参数,以及基于包含在肿瘤细胞中的细胞周期蛋白的表达水平的第四参数。 第一比较步骤包括将第一阈值与第三参数进行比较。 第二比较包括将第二阈值与第四参数进行比较。 判断步骤包括基于第一比较步骤和第二比较步骤的比较结果判断恶性肿瘤的特征。

    Method for judging feature of malignant tumor
    6.
    发明授权
    Method for judging feature of malignant tumor 失效
    判断恶性肿瘤特征的方法

    公开(公告)号:US08041514B2

    公开(公告)日:2011-10-18

    申请号:US11711053

    申请日:2007-02-27

    IPC分类号: G01N33/574 G06F19/00

    摘要: A method for judging feature of malignant tumor is described. The method comprises obtaining step, first comparing step, second comparing step and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first cyclin dependent kinase (first CDK) contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second cyclin dependent kinase (second CDK) contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a cyclin contained in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature of the malignant tumor based on the comparison results of the first comparing step and the second comparing step.

    摘要翻译: 描述了判断恶性肿瘤特征的方法。 该方法包括获得步骤,第一比较步骤,第二比较步骤和判断步骤。 获得步骤包括基于包含在恶性肿瘤的肿瘤细胞中的第一细胞周期依赖性激酶(第一CDK)的活性和表达水平获得第一参数,第二参数基于第二细胞周期蛋白依赖性激酶的活性和表达水平( 第二CDK),基于第一参数和第二参数的第三参数,以及基于包含在肿瘤细胞中的细胞周期蛋白的表达水平的第四参数。 第一比较步骤包括将第一阈值与第三参数进行比较。 第二比较包括将第二阈值与第四参数进行比较。 判断步骤包括基于第一比较步骤和第二比较步骤的比较结果判断恶性肿瘤的特征。

    EFFECT PREDICTING APPARATUS, COMPUTER PROGRAM PRODUCT, AND METHOD FOR PREDICTING AN EFFECT
    7.
    发明申请
    EFFECT PREDICTING APPARATUS, COMPUTER PROGRAM PRODUCT, AND METHOD FOR PREDICTING AN EFFECT 审中-公开
    效果预测装置,计算机程序产品和预测效果的方法

    公开(公告)号:US20100250483A1

    公开(公告)日:2010-09-30

    申请号:US12569130

    申请日:2009-09-29

    IPC分类号: G06N5/02

    CPC分类号: G16C20/30 G16B25/00

    摘要: An effect predicting apparatus for predicting an effect of anthracycline anticancer drugs, comprising: a display, a processor, and a memory, under control of said processor, including software instructions adapted to enable the processor to perform operations, comprising: acquiring a CDK parameter based on a first CDK parameter and a second CDK parameter; acquiring an expression level of glutathione; comparing the CDK parameter with a CDK threshold value, and the expression level of glutathione with a glutathione threshold value; predicting an effect of anthracycline anticancer drugs based on the result of the comparison; and displaying the result of the prediction. A computer program product and a method for predicting an effect are also disclosed.

    摘要翻译: 一种用于预测蒽环类抗癌药物的效果的效果预测装置,包括:在所述处理器的控制下的显示器,处理器和存储器,包括适于使处理器执行操作的软件指令,包括:基于CDK参数获取 第一个CDK参数和第二个CDK参数; 获得谷胱甘肽的表达水平; 将CDK参数与CDK阈值进行比较,以及谷胱甘肽阈值的谷胱甘肽的表达水平; 基于比较结果预测蒽环类抗癌药物的作用; 并显示预测结果。 还公开了一种用于预测效果的计算机程序产品和方法。

    Method for judging risk of cancer recurrence, computer program, and computer system
    9.
    发明授权
    Method for judging risk of cancer recurrence, computer program, and computer system 有权
    判断癌症复发风险的方法,计算机程序和计算机系统

    公开(公告)号:US08583588B2

    公开(公告)日:2013-11-12

    申请号:US13074745

    申请日:2011-03-29

    IPC分类号: G06F17/00 C12Q1/68 G06F19/18

    摘要: A method for judging a risk of cancer recurrence comprising: acquiring an activity value and expression level of a first cyclin dependent kinase (CDK) of a cell contained in tissues extracted from cancer patients, an activity value and expression level of a second CDK, and a number of Ki67-expressing cells or an expression level of Ki67; and judging a risk of cancer recurrence based on the acquired activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and a percentage of Ki67-expressing cells or the expression level of Ki67. A computer program product and a computer system are also disclosed.

    摘要翻译: 一种判断癌症复发风险的方法,包括:获得癌症患者提取的组织中含有的细胞的第一细胞周期蛋白依赖性激酶(CDK)的活性值和表达水平,第二CDK的活性值和表达水平,以及 多个Ki67表达细胞或Ki67表达水平; 根据获得的第一CDK的活性值和表达水平,第二CDK的活性值和表达量以及Ki67表达细胞的百分比或Ki67的表达水平来判断癌症复发的风险。 还公开了一种计算机程序产品和计算机系统。